πŸ›οΈ Verified NIH Record β€’ Updated 2025-08-12

Evaluation of a Device to Reduce Motion Sickness and Spatial Disorientation (NCT06892340)

A Non-Invasive, Non-Sedating Device to Mitigate Motion Sickness and Spatial Disorientation

🟒 Recruiting Observational / Diagnostic βš™οΈ Medical Device Protocol Sponsor: 59th Medical Wing

🩺 Plain-English Summary (8th-Grade Level)

The purpose of this research study is to learn how a wearable nerve stimulation device, the Spark Biomedical's Sparrow Ascent Systemβ„’, impacts the development of spatial disorientation and/or motion sickness in a healthy population. Spatial disorientation is when there is a "mismatch" between where a person is, and where the sense organs in their body tell them where they are. These sense organs include the inner ear (the vestibular system), the eyes (the visual system), the sense of where one's legs, back, and neck are (proprioceptive system), and one's higher thinking (cognitive centers). If spatial disorientation is severe or occurs in motion-naΓ―ve individuals, spatial disorientation can lead to motion sickness. The Sparrow Ascent Systemβ„’ is a wearable, battery-operated transcutaneous auricular (ear) neurostimulation (tAN) device. This means that it uses electrical pulses to stimulate branches of nerves on and/or around the ear, specifically the "vagus" and "trigeminal" nerves. These nerves are also responsible for your sensation of nausea and your heart rate (vagus nerve), as well as headaches (trigeminal nerve). The Sparrow System utilizes a flexible earpiece with embedded hydrogel electrodes that stick to the skin, the earpiece is disposable after use. This device is already Food and Drug Administration (FDA) approved for use in humans and is safely used for control of symptoms in a variety of other medical conditions, such as opioid withdrawal and acute stress reaction. In this study, we will determine if the Sparrow Ascent Systemβ„’ impacts the development of spatial disorientation or motion sickness.

Who can join: Review the eligibility criteria below.

Location: Randolph AFB Physiology lab β€” San Antonio, Texas

Age range: 18 Years to 50 Years

πŸ§ͺ Interventions in This Study

πŸ“‹ "Do I Qualify?" β€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria β†—

πŸ“ All Participating Trial Locations (1 Sites)

  • Randolph AFB Physiology lab β€” San Antonio, Texas

πŸ“ž Contact the Study Coordinator

Phone: (210) 916-2985

Email: isaac.d.erbele.mil@health.mil

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

πŸ’° Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA Β§ 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Motion Sickness clinical trials

πŸ’‘ How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
πŸ›οΈ View Official NIH Record β†—